Oppenheimer Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Oppenheimer Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,645	Closed	-$412K	–	1636
2018 Q3	$412K	Buy	26,645 +440	+2%	+$6.96K	0.01%	876
2018 Q2	$420K	Sell	26,205 -1,909	-7%	-$28.3K	0.01%	856
2018 Q1	$363K	Buy	28,114 +168	+0.6%	+$2.09K	0.01%	872
2017 Q4	$369K	Hold	27,946	–	–	0.01%	876
2017 Q3	$369K	Buy	27,946 +6,600	+31%	+$90.8K	0.01%	880
2017 Q2	$338K	Buy	21,346 +18,262	+592%	+$265K	0.01%	890
2017 Q1	$44K	Buy	+3,084	New	+$42.2K	﹤0.01%	1377

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer Asset Management's IRWD Position: Q4 2018 in Review

Oppenheimer Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2018, closing a stake of 26,645 shares — an estimated $412K sold.

Oppenheimer Asset Management first reported a position in IRWD in Q1 2017 and held it in 7 quarters. The position peaked at $420K in Q2 2018. 145 funds tracked by Wall St. Rank hold IRWD as of Q4 2018.

Oppenheimer Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Oppenheimer Asset Management sold 26,645 Ironwood Pharmaceuticals shares in Q4 2018, an estimated $412K.
Oppenheimer Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2017 and held it in 7 quarters.
Oppenheimer Asset Management's Ironwood Pharmaceuticals position peaked at $420K in Q2 2018.
145 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2018.

Based on Oppenheimer Asset Management's 13F filing for Q4 2018, filed 30 Jan 2019.